Payment overview · 2025
General Payments
$90.24
1 reported records · 1 companies
Healthcare provider profile · identity verified
Beth Ann Evans, D.O.
Allopathic & Osteopathic Physicians|Internal Medicine · ABITA SPRINGS, LA · NPI 1386744704
Verified facts
What the public records show
CMS Open Payments records show Beth Ann Evans, D.O. received $90.24 in general payments during 2025 across 1 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $90.24 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $90.24 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 502 | 113 |
| Amlodipine Besylate | Amlodipine Besylate | 421 | 129 |
| Atorvastatin Calcium | Atorvastatin Calcium | 374 | 119 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 348 | 99 |
| Pantoprazole Sodium | Pantoprazole Sodium | 277 | 81 |
| Gabapentin | Gabapentin | 274 | 80 |
| Losartan Potassium | Losartan Potassium | 231 | 67 |
| Metoprolol Succinate | Metoprolol Succinate | 208 | 61 |
| Alendronate Sodium | Alendronate Sodium | 182 | 49 |
| Fluticasone Propionate | Fluticasone Propionate | 170 | 68 |
| Duloxetine Hcl | Duloxetine Hcl | 167 | 38 |
| Pravastatin Sodium | Pravastatin Sodium | 165 | 48 |
| Trazodone Hcl | Trazodone Hcl | 118 | 28 |
| Sertraline Hcl | Sertraline Hcl | 117 | 31 |
| Escitalopram Oxalate | Escitalopram Oxalate | 116 | 38 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 113 | 35 |
| Omeprazole | Omeprazole | 109 | 33 |
| Mounjaro | Tirzepatide | 108 | 16 |
| Repatha Sureclick | Evolocumab | 107 | 19 |
| Eliquis | Apixaban | 99 | 24 |
| Hydrochlorothiazide | Hydrochlorothiazide | 96 | 32 |
| Metformin Hcl Er | Metformin Hcl | 90 | 28 |
| Metformin Hcl | Metformin Hcl | 85 | 27 |
| Carvedilol | Carvedilol | 84 | 23 |
| Furosemide | Furosemide | 83 | 29 |
| Benazepril Hcl | Benazepril Hcl | 82 | 23 |
| Valsartan | Valsartan | 80 | 23 |
| Famotidine | Famotidine | 78 | 28 |
| Fluoxetine Hcl | Fluoxetine Hcl | 77 | 20 |
| Ezetimibe | Ezetimibe | 76 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 74 | 26 |
| Paroxetine Hcl | Paroxetine Hcl | 73 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 73 | 29 |
| Meloxicam | Meloxicam | 69 | 25 |
| Ozempic | Semaglutide | 67 | 15 |
| Pregabalin | Pregabalin | 66 | 15 |
| Buspirone Hcl | Buspirone Hcl | 65 | 23 |
| Jardiance | Empagliflozin | 63 | 18 |
| Citalopram Hbr | Citalopram Hydrobromide | 61 | 16 |
| Potassium Chloride | Potassium Chloride | 61 | 16 |
| Prednisone | Prednisone | 56 | 45 |
| Clonazepam | Clonazepam | 55 | 11 |
| Metoprolol Tartrate | Metoprolol Tartrate | 53 | 17 |
| Fenofibrate | Fenofibrate | 52 | 13 |
| Lisinopril | Lisinopril | 51 | 15 |
| Spironolactone | Spironolactone | 50 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 50 | 15 |
| Bupropion Hcl | Bupropion Hcl | 49 | 11 |
| Repatha Syringe | Evolocumab | 49 | suppressed |
| Irbesartan | Irbesartan | 48 | 14 |
| Simvastatin | Simvastatin | 48 | suppressed |
| Tamsulosin Hcl | Tamsulosin Hcl | 48 | 16 |
| Propranolol Hcl Er | Propranolol Hcl | 47 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 47 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 43 | 15 |
| Cefdinir | Cefdinir | 42 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 42 | 13 |
| Tramadol Hcl | Tramadol Hcl | 42 | 13 |
| Allopurinol | Allopurinol | 41 | suppressed |
| Celecoxib | Celecoxib | 40 | suppressed |
| Bupropion Xl | Bupropion Hcl | 39 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 39 | suppressed |
| Atenolol | Atenolol | 37 | suppressed |
| Methocarbamol | Methocarbamol | 37 | 15 |
| Farxiga | Dapagliflozin Propanediol | 36 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 36 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 36 | 12 |
| Myrbetriq | Mirabegron | 36 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 35 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 35 | 14 |
| Trulicity | Dulaglutide | 35 | suppressed |
| Telmisartan | Telmisartan | 34 | 11 |
| Nortriptyline Hcl | Nortriptyline Hcl | 33 | 11 |
| Donepezil Hcl | Donepezil Hcl | 31 | suppressed |
| Fluconazole | Fluconazole | 30 | 16 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 30 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 25 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 28 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | 26 |
| Alprazolam | Alprazolam | 27 | 12 |
| Azithromycin | Azithromycin | 27 | 24 |
| Valacyclovir | Valacyclovir Hcl | 26 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 25 | suppressed |
| Ondansetron Odt | Ondansetron | 25 | suppressed |
| Acyclovir | Acyclovir | 24 | suppressed |
| Baclofen | Baclofen | 24 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 24 | suppressed |
| Mirtazapine | Mirtazapine | 24 | suppressed |
| Topiramate | Topiramate | 24 | suppressed |
| Aripiprazole | Aripiprazole | 23 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 23 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 23 | suppressed |
| Chlorthalidone | Chlorthalidone | 22 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 22 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 21 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 21 | suppressed |
| Estradiol | Estradiol | 20 | suppressed |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Linzess | Linaclotide | 20 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 20 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 19 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 19 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 19 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 19 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Methylprednisolone | Methylprednisolone | 18 | 18 |
| Quetiapine Fumarate | Quetiapine Fumarate | 18 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | suppressed |
| Verapamil Er | Verapamil Hcl | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Lorazepam | Lorazepam | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Synthroid | Levothyroxine Sodium | 15 | suppressed |
| Tradjenta | Linagliptin | 15 | suppressed |
| Mupirocin | Mupirocin | 14 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 14 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | 13 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 13 | suppressed |
| Glimepiride | Glimepiride | 13 | suppressed |
| Levetiracetam | Levetiracetam | 13 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Memantine Hcl | Memantine Hcl | 12 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 12 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 12 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Glipizide Er | Glipizide | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $90.24 · 1 records | Amgen Inc. | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error